Oxitropium bromide

Oxitropium bromide is an anticholinergic bronchodilator medication used for the treatment of chronic obstructive pulmonary disease (COPD) and asthma. It is not available in the United States but is used in many other countries, including Japan and those in Europe. It is grouped under the following drug class(es): Anticholinergics and Bronchodilators. Its therapeutic use is listed as anti-asthmatic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Oxivent, Ventilat and Tersigan. Its PubChem CID is 6917865.

CAS No 30286-75-0
Molecular Formula C19H26BrNO4
Molecular Weight 412.3 g/mol
Synonyms [(1R,2R,4S,5S)-9-ethyl-9-methyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate bromide

Frequently Asked Questions